Compare · BOAC vs ORIA
BOAC vs ORIA
Side-by-side comparison of Bluescape Opportunities Acquisition Corp. (BOAC) and Orion Biotech Opportunities Corp. (ORIA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BOAC and ORIA operate in Blank Checks (Finance), so they compete in similar markets.
- BOAC is the larger of the two at $743.4M, about 3.1x ORIA ($242.0M).
Bluescape Opportunities Acquisition Corp.
Bluescape Opportunities Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Dallas, Texas.
Orion Biotech Opportunities Corp.
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
Latest BOAC
- SEC Form SC 13G/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- Bluescape Opportunities Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form 25-NSE filed by Bluescape Opportunities Acquisition Corp.
- Bluescape Opportunities Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Bluescape Opportunities Acquisition Corp. Will Redeem its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form 10-Q filed by Bluescape Opportunities Acquisition Corp.
- SEC Form 10-Q/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- SEC Form 10-K/A filed by Bluescape Opportunities Acquisition Corp. (Amendment)
- SEC Form 10-Q filed by Bluescape Opportunities Acquisition Corp.
- SEC Form 10-K filed by Bluescape Opportunities Acquisition Corp.
Latest ORIA
- SEC Form SC 13G/A filed by Orion Biotech Opportunities Corp. (Amendment)
- SEC Form 4 filed by Collins James J.
- SEC Form 4 filed by Broder Samuel
- SEC Form 4 filed by Orion Sponsor Holdings, Llc
- SEC Form 4 filed by Rodriguez Louisa
- SEC Form 15-12G filed by Orion Biotech Opportunities Corp.
- SEC Form 25 filed by Orion Biotech Opportunities Corp.
- Orion Biotech Opportunities Says Will Redeem Public Share, Will Not Consummate Initial Business Combination
- Orion Biotech Opportunities Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 10-K filed by Orion Biotech Opportunities Corp.